Design, synthesis and structure-affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands

Bioorganic and Medicinal Chemistry

Volumn 12, Issue 2, 2004, Pages 423-438

  Okubo, Taketoshi ^a   Yoshikawa, Ryoko ^a   Chaki, Shigeyuki ^a   Okuyama, Shigeru ^a   Nakazato, Atsuro ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANILIDE; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; DIAZEPAM; IMIDAZOPYRIDINE DERIVATIVE; INDOLE DERIVATIVE; ISOQUINOLINE DERIVATIVE; LIGAND; N (2,5 DIMETHOXYBENZYL) N (4 FLUORO 2 PHENOXYPHENYL)ACETAMIDE; N (4 CHLORO 2 PHENOXYPHENYL) N (2 ISOPROPOXYBENZYL)ACETAMIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; IC 50; KIDNEY; NONHUMAN; PHYSIOLOGY; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; RAT; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION;

EID: 0346690184     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2003.10.050     Document Type: Article

References (43)

1. Braestrup C., Squires R.F. Proc. Natl. Acad. Sci. U.S.A. 74:1977;3805.
2. DeLorey T.M., Olsen R.W. J. Biol. Chem. 267:1992;16747.
3. Möhler H., Okada T. Science (Washington, DC). 198:1977;849.
4. Tallmann J.F., Paul S.M., Skolnick P., Gallager D.W. Science (Washington, DC). 207:1980;274.
5. Drugan R.C. Clin. Neuropharmacol. 19:1996;475.
6. Papadopoulos V. Endocr. Rev. 14:1993;222.
7. Woods M.J., Williams D.C. Biochem. Pharmacol. 52:1996;1805.
8. Olson J.M., Ciliax B.J., Mancini W.R., Young A.B. Eur. J. Pharmacol. 152:1988;47.
9. Syapin P.J., Skolnick P. J. Neurochem. 32:1979;1047.
10. Gallager D.W., Mallorga P., Oertel W., Henneberry R., Tallman T. J. Neurosci. 1:1981;218.
11. Joseph-Laiuzun E., Delmas P., Shire D., Ferrara P. J. Biol. Chem. 273:1998;2146.
12. Cahard D., Canat X., Carayon P., Roque C., Casellas P., Le Fur G. Lab. Invest. 70:1994;23.
13. Anholt R.R., Pedersen P.L., De Souza E.B., Snyder S.H. J. Biol. Chem. 261:1986;576.
14. Bribes E., Casellas P., Vidal H., Dussossoy D., Casellas D. J. Am. Soc. Nephrol. 13:2002;1.
15. McEnery M.W., Snowman A.M., Trifiletti R.R., Snyder S.H. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3170.
16. Riond J., Mattei M.G., Kaghad M., Dumont X., Guillemot J.C., Le Fur G., Caput D., Ferrara P. Eur. J. Biochem. 195:1991;305.
17. Parola A.L., Stump D.G., Pepperl D.J., Krueger K.E., Regan J.W., Laird 2nd H.E. J. Biol. Chem. 266:1991;14082.
18. Sprengel R., Werner P., Seeburg P.H., Mukhin A.G., Santi M.R., Grayson D.R., Guidotti A., Krueger K.E. J. Biol. Chem. 264:1989;20415.
19. Garnier M., Dimchev A.B., Boujrad N., Price J.M., Musto N.A., Papadopoulos V. Mol. Pharmacol. 45:1994;201.
20. Carmel I., Fares F.A., Leschiner S., Scherübl H., Weisinger G., Gavish M. Biochem. Pharmacol. 59:1999;3170.
21. Kelly-Hershkovitz E., Weizman R., Spanier I., Leschiner S., Lahav M., Weisinger G., Gavish M. J. Biol. Chem. 273:1998;3170.
22. Python C.P., Rossier M.F., Vallotton M.B., Capponi A.M. Endocrinology. 132:1993;1489.
23. Hirsch J.D., Beyer C.F., Malkowitz L., Beer B., Blume A. J. Mol. Pharmacol. 35:1989;1489.
24. Lenfant M., Haumont J., Zavala F. Int. J. Immunopharmacol. 8:1986;825.
25. Alenfall J., Batra S. Life Sci. 56:1995;1897.
26. Mantione C.R., Goldman M.E., Martin B., Bolger G.T., Lueddens H.W.M., Paul S.M., Skolnick P. Biochem. Pharmacol. 37:1988;339.
27. Corda M.G., Ferrari M., Guidotti A., Konkel D., Costa E. Neurosci. Lett. 47:1984;310.
28. Ferrero P., Costa E., Conti-Tronconi B., Guidotti A. Brain Res. 399:1986;136.
29. Gray P.W., Glaister D., Seeburg P.H., Guidotti A., Costa E. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7547.
30. Snyder S.H., Verma A., Trifiletti R.R. FASEB J. 1:1987;282.
31. Marangos P.J., Patel J., Boulenger J.P., Clark-Rosengerg R. Mol. Pharmcol. 22:1982;26.
32. Le Fur G., Vaucher N., Perrier M.L., Flamier A., Benavides J., Renault C., Dubroeucq M.C., Gueremy C., Uzan A. Life Sci. 33:1983;449.
33. Selleri S., Bruni F., Costagli C., Costanzo A., Guerrini G., Ciciani G., Costa B., Martini C. Bioorg. Med. Chem. 9:2001;2661.
34. Farges R., Joseph-Liauzum E., Shire D., Caput D., Le Fur G., Ferrara P. Mol. Pharmacol. 46:1994;1160.
35. Farges R., Joseph-Liauzum E., Shire D., Caput D., Le Fur G., Loison G., Ferrara P. FEBS Lett. 335:1993;305.
36. Basile A.S., Klein D.C., Skolnick P. Mol. Brain Res. 1:1986;127.
37. Bolger G.T., Weissman B.A., Lueddens H., Basile A.S., Mantione C.R., Barrett J.M., Witkin J.M., Paul S.M., Skolnick P. Brain Res. 338:1985;366.
38. Langer S.Z., Arbilla S. Pharmacol. Biochem. Behav. 29:1988;763.
39. Romeo E., Auta J., Kozikowski A.P., Ma D., Papadopoulos V., Puia G., Costa E., Guidotti A. J. Pharmacol. Exp. Ther. 262:1992;971.
40. Kozikowski A.P., Ma D., Brewer J., Sun S., Costa E., Romeo E., Guidotti A. J. Med. Chem. 36:1993;2908.
41. Okuyama S., Chaki S., Yoshikawa R., Ogawa S., Suzuki Y., Okubo T., Nakazato A., Nagamine M., Tomisawa K. Life Sci. 64:1999;1455.
42. Chaki S., Okuyama S., Funakoshi T., Yoshikawa R., Okuyama S., Okubo T., Nakazato A., Nagamine M., Tomisawa K. Eur. J. Pharm. 371:1999;197.
43. Gulty M., Silver P., Nakazato A., Gazouli M., Li H., Muramatsu M., Okuyama S., Papadopoulos V. Drug Develop. Res. 52:2001;475.